Gradual hypertension induction in middle-aged Cyp1a1-Ren2 transgenic rats produces significant impairments in spatial learning.


Journal

Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800

Informations de publication

Date de publication:
03 2019
Historique:
received: 24 06 2018
revised: 16 12 2018
accepted: 18 12 2018
entrez: 28 3 2019
pubmed: 28 3 2019
medline: 28 4 2020
Statut: ppublish

Résumé

Hypertension is a major health concern in the developed world, and its prevalence increases with advancing age. The impact of hypertension on the function of the renal and cardiovascular systems is well studied; however, its influence on the brain regions important for cognition has garnered less attention. We utilized the Cyp1a1-Ren2 xenobiotic-inducible transgenic rat model to mimic both the age of onset and rate of induction of hypertension observed in humans. Male, 15-month-old transgenic rats were fed 0.15% indole-3-carbinol (I3C) chow to slowly induce renin-dependent hypertension over a 6-week period. Systolic blood pressure significantly increased, eventually reaching 200 mmHg by the end of the study period. In contrast, transgenic rats fed a control diet without I3C did not show significant changes in blood pressure (145 mmHg at the end of study). Hypertension was associated with cardiac, aortic, and renal hypertrophy as well as increased collagen deposition in the left ventricle and kidney of the I3C-treated rats. Additionally, rats with hypertension showed reduced savings from prior spatial memory training when tested on the hippocampus-dependent Morris swim task. Motor and sensory functions were found to be unaffected by induction of hypertension. Taken together, these data indicate a profound effect of hypertension not only on the cardiovascular-renal axis but also on brain systems critically important for learning and memory. Future use of this model and approach may empower a more accurate investigation of the influence of aging on the systems responsible for cardiovascular, renal, and neurological health.

Identifiants

pubmed: 30916484
doi: 10.14814/phy2.14010
pmc: PMC6436186
doi:

Substances chimiques

Indoles 0
indole-3-carbinol C11E72455F
Cytochrome P-450 CYP1A1 EC 1.14.14.1
Renin EC 3.4.23.15

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14010

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL144779
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG049464
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104940
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007609
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States

Informations de copyright

© 2019 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

Références

Eur J Pharmacol. 2015 Jan 5;746:138-47
pubmed: 25446433
J Renin Angiotensin Aldosterone Syst. 2014 Mar;15(1):69-81
pubmed: 23462119
Neurosci Biobehav Rev. 2006;30(6):730-48
pubmed: 16919333
J Biol Chem. 2001 Sep 28;276(39):36727-33
pubmed: 11448960
MMWR Suppl. 2013 Nov 22;62(3):144-8
pubmed: 24264505
Behav Neurosci. 1993 Aug;107(4):618-26
pubmed: 8397866
Hypertension. 2016 Dec;68(6):e67-e94
pubmed: 27977393
Physiol Behav. 1996 Aug;60(2):341-5
pubmed: 8840889
Physiol Behav. 2013 Jan 17;109:63-8
pubmed: 23103834
Brain Res. 1992 Oct 2;592(1-2):135-40
pubmed: 1450905
Hypertension. 2000 Dec;36(6):1079-82
pubmed: 11116128
Behav Brain Res. 2018 Jul 2;346:29-40
pubmed: 29229547
J Cereb Blood Flow Metab. 2012 Feb;32(2):248-55
pubmed: 21971355
Hypertension. 2008 Jan;51(1):99-104
pubmed: 18025297
Science. 1971 May 28;172(3986):959-62
pubmed: 5573571
Neurobiol Aging. 1996 May-Jun;17(3):439-51
pubmed: 8725906
Hypertension. 1998 Mar;31(3):780-6
pubmed: 9495261
Physiol Rep. 2019 Mar;7(6):e14010
pubmed: 30916484
J Renin Angiotensin Aldosterone Syst. 2006 Jun;7(2):74-86
pubmed: 17083061
J Cereb Blood Flow Metab. 2015 Feb;35(2):188-92
pubmed: 25407269
J Am Heart Assoc. 2013 Dec 18;2(6):e000369
pubmed: 24351701
Hypertens Res. 2016 Jan;39(1):8-18
pubmed: 26490086
Brain Res. 2015 Oct 5;1622:279-91
pubmed: 26168894
J Anesth. 2017 Feb;31(1):25-35
pubmed: 27738803
JAMA. 1995 Dec 20;274(23):1846-51
pubmed: 7500533
Oncotarget. 2017 Sep 27;8(56):95780-95790
pubmed: 29221166
JAMA Neurol. 2017 Oct 1;74(10):1246-1254
pubmed: 28783817
Hypertension. 1999 Sep;34(3):496-502
pubmed: 10489400
Neuroscience. 2001;103(2):351-63
pubmed: 11246150
Brain Behav Immun. 2018 May;70:214-232
pubmed: 29518527
Mech Ageing Dev. 1991 Jun 14;59(1-2):197-213
pubmed: 1890883
J Am Soc Hypertens. 2013 Nov-Dec;7(6):411-9
pubmed: 24119481
Hypertension. 2014 Nov;64(5):983-8
pubmed: 25156174
Neurology. 2009 Aug 25;73(8):589-95
pubmed: 19704077

Auteurs

Mari N Willeman (MN)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Neurogenomics Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Monica K Chawla (MK)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Marc A Zempare (MA)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Lauren A Biwer (LA)

Department of Basic Medical Sciences, University of Arizona, College of Medicine - Phoenix, Phoenix, Arizona.

Lan T Hoang (LT)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Ajay R Uprety (AR)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Megan C Fitzhugh (MC)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.
Department of Psychology, University of Arizona, Tucson, Arizona.

Matthew De Both (M)

Neurogenomics Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Paul D Coleman (PD)

Arizona Alzheimer's Consortium, Phoenix, Arizona.
Center for Neurodegenerative Disease Research, Biodesign Institute, Arizona State University, Tempe, Arizona.

Theodore P Trouard (TP)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Department of Biomedical Engineering and Medical Imaging, University of Arizona, Tucson, Arizona.

Gene E Alexander (GE)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.
Department of Psychology, University of Arizona, Tucson, Arizona.
Neuroscience and Physiological Sciences Graduate Interdisciplinary Programs, University of Arizona, Tucson, Arizona.

Kenneth D Mitchell (KD)

Department of Physiology, Tulane University Health Sciences Center, New Orleans, Los Angeles.

Carol A Barnes (CA)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.
Department of Psychology, University of Arizona, Tucson, Arizona.

Taben M Hale (TM)

Department of Basic Medical Sciences, University of Arizona, College of Medicine - Phoenix, Phoenix, Arizona.

Matthew Huentelman (M)

Evelyn F. McKnight Brain Institute, University of Arizona, Tucson, Arizona.
Neurogenomics Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona.
Arizona Alzheimer's Consortium, Phoenix, Arizona.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH